SAN DIEGO, CA / ACCESS Newswire / / , Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company") a clinical-stage biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an ...
Zacks Investment Research on MSN
Caribou Biosciences (CRBU) loses 19.6% in 4 weeks, here's why a trend reversal may be around the corner
Caribou Biosciences, Inc. (CRBU) has been on a downward spiral lately with significant selling pressure. After declining 19.6% over the past four weeks, the stock looks well positioned for a trend ...
NDA supported by positive results from the APEX pivotal trial demonstrating clinically meaningful responses and evidence of disease modification in patients with AdvSM PDUFA target action date set for ...
Yarrow intends to use the net proceeds from this offering to fund research and development expenses for Yarrow’s pipeline and general corporate purposes, which may include working capital, capital ...
6don MSN
Inhibrx Biosciences plans head and neck cancer trial expansion following high response rates
Inhibrx Biosciences Inc. INBX announced primary endpoint results from the randomized Phase 2 portion of its HexAgon study. • ...
To supplement Niagen Bioscience’s unaudited financial data presented in accordance with generally accepted accounting principles (GAAP), the Company has presented Adjusted EBITDA, a non-GAAP financial ...
SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science ...
View Tyra Bioscience, Inc TYRA stock quote prices, financial information, real-time forecasts, and company news from CNN.
Tyra Biosciences Inc. ( TYRA) shares are currently trading at $20.77, down $5.96, or 22.27 percent on Wednesday, despite the company reporting encouraging initial results from its Phase 2 SURF302 ...
View Satellos Bioscience Inc MSLE stock quote prices, financial information, real-time forecasts, and company news from CNN.
Hello, and thank you for joining the Daré Bioscience's Virtual Bus Tour. My name is Justin Romanowski, Managing Director of JTC IR, and I'll be the moderator for today's event. Today, the company will ...
Good day, and welcome to the Third Quarter 2025 Harvard Bioscience Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results